会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Process control apparatus and laser processing apparatus
    • 过程控制装置和激光加工装置
    • US08648279B2
    • 2014-02-11
    • US12936120
    • 2009-04-03
    • Keiji TakahashiTomonori MukaeShigeru YokoiTatsuya Yamamoto
    • Keiji TakahashiTomonori MukaeShigeru YokoiTatsuya Yamamoto
    • B23K26/04
    • B23K26/046G02B7/008G02B7/028
    • A process control apparatus controls a focus position of a laser beam, while a laser processing mechanism converges the laser beam into a predetermined focus position and performs a laser processing on a workpiece. The process control apparatus includes: a calculator that, based on the magnitude of an output of the laser beam that changes during the laser processing, calculates a change amount of a positional deviation of the focus position in an optical axis direction that changes during the laser processing at a laser beam radiation position; and a control unit that, based on the change amount of the positional deviation that has been calculated by the calculator, controls the focus position of the laser beam during the laser processing so as to resolve the positional deviation of the focus position.
    • 过程控制装置控制激光束的焦点位置,而激光加工机构将激光束会聚到预定的聚焦位置,并对工件进行激光加工。 该处理控制装置包括:计算器,其基于在激光处理期间发生变化的激光束的输出的大小来计算在激光器内变化的光轴方向上的聚焦位置的位置偏差的变化量 在激光束辐射位置处理; 以及控制单元,其基于由计算器计算出的位置偏差的变化量来控制激光处理期间的激光束的聚焦位置,以便解析聚焦位置的位置偏差。
    • 3. 发明授权
    • Aryloxy-substituted benzimidazole derivatives
    • 芳氧基取代的苯并咪唑衍生物
    • US07932394B2
    • 2011-04-26
    • US11666555
    • 2005-11-01
    • Noriaki HashimotoKeiji TakahashiChisato NakamaYoshio OginoFumiko SakaiTeruyuki NishimuraJun-ichi Eiki
    • Noriaki HashimotoKeiji TakahashiChisato NakamaYoshio OginoFumiko SakaiTeruyuki NishimuraJun-ichi Eiki
    • C07D401/00A61K31/445
    • A61K38/31A61K31/155A61K31/4439A61K31/444A61K31/4545A61K31/497A61K31/506A61K38/28A61K45/06C07D401/04C07D401/14C07D413/06C07D413/14A61K2300/00
    • A glucokinase activator is provided; and a treatment and/or a preventive for diabetes, or a treatment and/or a preventive for diabetes such as retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis, and further a treatment and/or a preventive for obesity are provided.The invention relates to a compound of a formula (I): [wherein R1 and R2 represent a hydrogen, etc.; R3 represents a hydrogen atom, a halogen atom, etc.; R4 each independently represents a hydrogen atom, a lower alkyl group, etc.; Q represents a carbon atom, a nitrogen atom or a sulfur atom (the sulfur atom may be mono- or di-substituted with an oxo group); R5 and R6 each represent a hydrogen atom, a lower alkyl group, etc.; X1, X2, X3 and X4 each independently represent a carbon atom or a nitrogen atom; Z represents an oxygen atom, a sulfur atom or a nitrogen atom; Ar represents an aryl or heteroaryl group optionally mono to tri-substituted with a group selected from the substituent group β; ring A represents a 5- or 6-membered nitrogen-containing heteroaromatic group; m indicates an integer of from 1 to 6; n indicates an integer of from 0 to 3; p indicates an integer of from 0 to 2 (provided that at least two of X1 to X4 are carbon atoms); q indicates 0 or 1] or its pharmaceutically-acceptable salt, which has an effect of glucokinase activation and is useful as a treatment for diabetes.
    • 提供葡糖激酶活化剂; 提供糖尿病的治疗和/或预防,或治疗和/或预防糖尿病如视网膜病,肾病,神经症,缺血性心脏病,动脉硬化,以及进一步的治疗和/或预防肥胖症。 本发明涉及式(I)化合物:其中R 1和R 2表示氢等; R3表示氢原子,卤原子等; R4各自独立地表示氢原子,低级烷基等; Q表示碳原子,氮原子或硫原子(硫原子可以被氧代基单取代或二取代)。 R5和R6各自表示氢原子,低级烷基等; X1,X2,X3和X4各自独立地表示碳原子或氮原子; Z表示氧原子,硫原子或氮原子; Ar表示任选被选自取代基组中的基团单取代至三取代的芳基或杂芳基; 环A表示5-或6-元含氮杂芳基; m表示1〜6的整数, n表示0〜3的整数, p表示0〜2的整数(X1〜X4中的至少2个为碳原子)。 q表示0或1]或其药学上可接受的盐,其具有葡糖激酶活化的作用,并且可用作糖尿病的治疗。